Page 26 - Read Online
P. 26

Sugawara et al. Hepatoma Res 2018;4:33  I  http://dx.doi.org/10.20517/2394-5079.2018.69                                          Page 5 of 5

                   liver transplantation. Clin Transplant 2011;25:E491-8.
               15.  Uchiyama H, Itoh S, Yoshizumi T, Ikegami T, Harimoto N, Soejima Y, Harada N, Morita K, Toshima T, Motomura T, Maehara Y. Living
                   donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7
                   years. HPB (Oxford) 2017;19:1082-90.
               16.  Lee SG, Moon DB, Shin H, Kim KH, Ahn CS, Ha TY, Song GW, Jung DH, Park GC. Living donor liver transplantation for
                   hepatocellular carcinoma: current status in Korea. Transplant Proc 2012;44:520-2.
               17.  Concejero A, Chen CL, Wang CC, Wang SH, Lin CC, Liu YW, Yang CH, Yong CC, Lin TS, Jawan B, Huang TL, Cheng YF, Eng HL.
                   Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation 2008;85:398-406.
               18.  Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, Chung D, Park G, Yu Y, Choi N, Kim K, Kim K, Hwang S. Liver transplantation for
                   hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Sci 2010;17:539-47.
               19.  Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. Liver transplantation for hepatocellular carcinoma: the Hong Kong
                   experience. J Hepatobiliary Pancreat Sci 2010;17:548-54.
               20.  Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.
                   Ann Surg 1998;228:479-90.
               21.  Ravaioli M, Grazi GL, Vetrone G, Kimura T, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Tuci F, Cucchetti A, La
                   Barba G, Vivarelli M, Lauro A, Ramacciato G, Pinna AD. A new liver transplant priority for patients with hepatocellular carcinoma.
                   Hepatogastroenterology 2008;55:1742-5.
               22.  Roche B, Samuel D. Prevention of hepatitis B virus reinfection in liver transplant recipients. Intervirology 2014;57:196-201.
               23.  Chen T, Terrault NA. Perspectives on treating hepatitis C infection in the liver transplantation setting. Curr Opin Organ Transplant
                   2016;21:111-9.
               24.  Sugawara Y, Hibi T. Direct-acting agents for hepatitis C virus before and after liver transplantation. Biosci Trends 2018;11:606-11.
   21   22   23   24   25   26   27   28   29   30   31